In a prespecified analysis of DANFLU-2 (332,438 adults ≥65 in Denmark), high- vs standard-dose flu vaccine relative effectiveness against flu/pneumonia admission rose with continuous frailty score (p=0.020), but not across frailty categories (p=0.17); exploratory.
Secondary analysisn = 332,438
Espersen et al. Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2